NHS efficiency drive to make savings of £20 billion

By Admin
A new watchdog group designed to drive efficiency and savings in the NHS has been announced by the Department of Health. The Steering Group to Improve...

A new watchdog group designed to drive efficiency and savings in the NHS has been announced by the Department of Health.

The Steering Group to Improve the Use of Medicines is aiming to make £20 billion worth of savings in the NHS by 2015.

The Group, which is made up of health experts and patient representatives, will also work to increase the quality of NHS services.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

This comes as the Department of Health is claiming at least £300 million is lost every year due to medical waste.

Additionally, a lack of patient adherence to prescriptions increases the cost of wastage to £500 million.

This is one problem area the Group will specifically target; identifying how patients can be supported in taking their prescribed medicines.

It is thought in turn this will help to improve their long-term health outcomes and subsequently ensure better value for the NHS.

Health Minister Lord Howe said in a statement: “We want to look at how patients can make the most of the medicines they take.

“This isn’t just about saving money, it’s about making sure that patients stay well and get the best outcomes from their medicines.”

He added: “Every pound wasted is a pound that could be spent on treating patients. By reducing medicine wastage the NHS will save money that can be spent in other areas of patient care.”

Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma